Zhejiang East Asia Pharmaceutical Co., Ltd. (SHA:605177)
China · Delayed Price · Currency is CNY 20.57
+0.13 (0.64%)
Apr 22, 2026, 1:36 PM CST
SHA:605177 Market Cap
SHA:605177 has a market cap or net worth of 2.3 billion as of April 21, 2026. Its market cap has increased by 4.36% in one year.
Market Cap
2.30B
Enterprise Value
2.91B
Revenue
831.56M
Ranking
n/a
PE Ratio
n/a
Stock Price
20.57
Market Cap Chart
Since November 25, 2020, SHA:605177's market cap has decreased from 5.09B to 2.30B, a decrease of -54.83%. That is a compound annual growth rate of -13.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 21, 2026 | 2.30B | 14.83% |
| Dec 31, 2025 | 2.00B | -9.67% |
| Dec 31, 2024 | 2.22B | -26.27% |
| Dec 29, 2023 | 3.01B | 32.27% |
| Dec 30, 2022 | 2.27B | -27.57% |
| Dec 31, 2021 | 3.14B | -22.14% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 25, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Guangdong VTR Bio-Tech | 2.99B |
| Suzhou Fushilai Pharmaceutical | 2.87B |
| Shanghai Hile Bio-Technology | 2.81B |
| Shandong Sito Bio-technology | 2.65B |
| Shanghai Universal Biotech | 2.62B |
| Hubei Goto Biopharm | 2.50B |
| Jilin Jian Yisheng Pharmaceutical | 2.49B |
| Sailong Pharmaceutical Group | 2.32B |